Table 1.
Inclusion criteria | Exclusion criteria |
Female sex | >5 years since menopause |
Occurrence of menopause | Surgical menopause |
Agreement to participate in the study and provision of informed consent | Treatment with bisphosphonates or other drugs used to treat osteoporosis |
Urinary phytate concentrations between 0.51 and 0.99 mg/L |